person
as of 2026-07-01Deanna L. Kelly, Pharm.D., BCPP
Deanna Kelly, Pharm.D., BCPPDeanna L Kelly, Parm.D., BCPPDeanna L Kelly, Pharm.D, BCPPDeanna L Kelly, Pharm.D., BCPPDeanna L Kelly, PharmD, BCPP
at a glance
Roles: Principal Investigator
KOL signal score 5
0 publications · 0 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
University of Maryland, College Park
Roles
Principal Investigator
KOL signal
5
Publications
0 (0 high-value)
Trial investigator
yes
Trials led
13
Ketogenic Diet in People With Schizophrenia
NCT05968638—Active Not Recruiting
Neuroendocrine and Immune Response to Stress in Schizophrenia
NCT01975584—Completed
Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin
NCT01558570—Completed
Screening Protocol for Research Participants
NCT01010620—Completed
Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia
NCT00770237—Completed
Gluten Free Diet in People With Schizophrenia: A Pilot Study
NCT01558557—Completed
Knowledge and Perception of Smoking Risks/Consequences
NCT00686101—Completed
Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)
NCT02404155—Completed
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients
NCT01433055—Completed
Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity
NCT02118610—Completed
Oxytocin and Social Cognition in Schizophrenia
NCT00884897Phase 2Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR